CHECKMATE PHARMACEUTICALS IN
CUSIP 162818108
Checkmate Pharmaceuticals In has 18 institutional holders in Filings Flow’s 13F database, together reporting 14.51M shares worth $42M as of Q4 2021. The largest reported holders are Venbio Partners LLC, Sofinnova Investments, Inc., and Novo Holdings A/S.
Institutional Holders
18
Q4 2021
Reported Value
$42M
Ticker
unmapped
private placement or foreign
Quarters Tracked
2
Ownership Trend
Institutional holders
Total reported value
Holders
Mixed quarters
| Manager | % of Portfolio | Value | Shares | Quarter |
|---|---|---|---|---|
| venBio Partners LLC$281M AUM | 2.60% | $12M | 3.67M | Q1 2022OLDER |
| Decheng Capital Management III (Cayman), LLC$300M AUM | 1.30% | $4M | 1.33M | Q1 2022OLDER |
| Sofinnova Investments, Inc.$2.6B AUM | 0.87% | $12M | 3.61M | Q1 2022OLDER |
| Omega Fund Management, LLC$163M AUM | 0.87% | $4M | 1.34M | Q1 2022OLDER |
| Novo Holdings A/S$1.2B AUM | 0.36% | $7M | 2.16M | Q1 2022OLDER |
| SECTORAL ASSET MANAGEMENT INC$121M AUM | 0.31% | $2M | 541.8K | Q1 2022OLDER |
| CLOUGH CAPITAL PARTNERS L P$1.0B AUM | 0.28% | $4M | 1.14M | Q1 2022OLDER |
| RBF Capital, LLC$2.0B AUM | 0.01% | $219,000 | 68.0K | Q1 2022OLDER |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC$5.0B AUM | 0.01% | $340,000 | 106.5K | Q1 2022OLDER |
| CAMBRIDGE TRUST CO$2.6B AUM | 0.00% | $79,000 | 24.6K | Q1 2022OLDER |
| JACOBS LEVY EQUITY MANAGEMENT, INC$23.8B AUM | 0.00% | $145,000 | 36.5K | Q3 2021OLDER |
| Ensign Peak Advisors, Inc$53.7B AUM | 0.00% | $268,000 | 93.3K | Q4 2021OLDER |
| FEDERATED HERMES, INC.$61.5B AUM | 0.00% | $98,000 | 30.6K | Q1 2022OLDER |
| Tower Research Capital LLC (TRC)$3.8B AUM | 0.00% | $6,000 | 1.9K | Q1 2022OLDER |
| RENAISSANCE TECHNOLOGIES LLC$63.9B AUM | 0.00% | $42,000 | 10.7K | Q3 2021OLDER |
| BARCLAYS PLC$416.3B AUM | 0.00% | $46,000 | 14.6K | Q1 2022OLDER |
| PNC FINANCIAL SERVICES GROUP, INC.$173.2B AUM | 0.00% | $20,000 | 5.0K | Q3 2021OLDER |
| GEODE CAPITAL MANAGEMENT, LLC$1.61T AUM | 0.00% | $132,000 | 41.5K | Q1 2022OLDER |
| MILLENNIUM MANAGEMENT LLC$240.3B AUM | 0.00% | $31,000 | 10.6K | Q4 2021OLDER |
| US BANCORP \DE\$82.4B AUM | 0.00% | $6,000 | 2.0K | Q1 2022OLDER |
| UBS Group AG$666.3B AUM | 0.00% | $1,000 | 183 | Q1 2022OLDER |
| Medicxi Ventures Management (Jersey) Ltd$982M AUM | — | $0 | 0 | Q2 2022 |
Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.